25 Aug 2023
According to a study published in the Journal of Diabetes Complications, semaglutide is more effective in helping manage type 2 diabetes than other GLP-1 receptor agonists, including greater reductions in HbA1C, body weight, waist circumference and cardiometabolic improvements.
Healio
Study using twins sees cardiovascular improvements with vegan diet
07 Dec 2023
Menarche at early age linked to increased diabetes risk
07 Dec 2023
In utero exposure to Covid-19 associated with preterm birth
07 Dec 2023
Type 2 diabetes risk may be reduced with fast walking
01 Dec 2023
Pomegranate consumption linked to prevention of metabolic disorders
01 Dec 2023